ARS Pharmaceuticals Inc (NASDAQ: SPRY)’s stock price has plunge by 1.36relation to previous closing price of 13.97. Nevertheless, the company has seen a -3.28% plunge
ARS Pharmaceuticals Inc (NASDAQ: SPRY) has a higher price-to-earnings ratio of 187.48x compared to its average ratio, The 36-month beta value for SPRY is at
The stock price of ARS Pharmaceuticals Inc (NASDAQ: SPRY) has plunged by -0.73 when compared to previous closing price of 14.99, but the company has
ARS Pharmaceuticals Inc (NASDAQ: SPRY) has a price-to-earnings ratio that is above its average at 159.13x. The stock has a 36-month beta value of 0.77.
The stock of ARS Pharmaceuticals Inc (SPRY) has seen a 3.15% increase in the past week, with a 23.66% gain in the past month, and
The stock of ARS Pharmaceuticals Inc (SPRY) has gone up by 4.13% for the week, with a 4.92% rise in the past month and a
The stock of ARS Pharmaceuticals Inc (SPRY) has gone up by 4.13% for the week, with a 4.92% rise in the past month and a
The stock of ARS Pharmaceuticals Inc (NASDAQ: SPRY) has increased by 1.04 when compared to last closing price of 11.53. Despite this, the company has
© 2024, Powered by Smart TechOne
